{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Mader L"],"funding":["Natural Sciences and Engineering Research Council of Canada","Canadian Institutes of Health Research"],"pagination":["277-298"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9945866"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(2)"],"pubmed_abstract":["Human tissue transglutaminase (hTG2) is a multifunctional enzyme with protein cross-linking and G-protein activity, both of which have been implicated in the progression of diseases such as fibrosis and cancer stem cell propagation when dysregulated, prompting the development of small molecule targeted covalent inhibitors (TCIs) possessing a crucial electrophilic 'warhead'. In recent years there have been significant advances in the library of warheads available for the design of TCIs; however, the exploration of warhead functionality in hTG2 inhibitors has remained relatively stagnant. Herein, we describe a structure-activity relationship study entailing rational design and synthesis for systematic variation of the warhead on a previously reported small molecule inhibitor scaffold, and ri"],"journal":["RSC medicinal chemistry"],"pubmed_title":["The war on hTG2: warhead optimization in small molecule human tissue transglutaminase inhibitors."],"pmcid":["PMC9945866"],"funding_grant_id":["RGPIN-2019-05893","PJT-162180"],"pubmed_authors":["Kaur H","Keillor JW","Iyer HR","Watt SKI","Mader L","Nguyen L"],"additional_accession":[]},"is_claimable":false,"name":"The war on hTG2: warhead optimization in small molecule human tissue transglutaminase inhibitors.","description":"Human tissue transglutaminase (hTG2) is a multifunctional enzyme with protein cross-linking and G-protein activity, both of which have been implicated in the progression of diseases such as fibrosis and cancer stem cell propagation when dysregulated, prompting the development of small molecule targeted covalent inhibitors (TCIs) possessing a crucial electrophilic 'warhead'. In recent years there have been significant advances in the library of warheads available for the design of TCIs; however, the exploration of warhead functionality in hTG2 inhibitors has remained relatively stagnant. Herein, we describe a structure-activity relationship study entailing rational design and synthesis for systematic variation of the warhead on a previously reported small molecule inhibitor scaffold, and ri","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2026-05-28T19:58:29.794Z","creation":"2025-04-21T15:33:25.124Z"},"accession":"S-EPMC9945866","cross_references":{"pubmed":["36846370"],"doi":["10.1039/d2md00378c"]}}